Amie Fonder

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

Eli Muchtar, Morie A. Gertz, Shaji Kumar et al. · Blood · 2017 · 342 citations · Full text

Medicine, Internal Medicine, Neurology +6

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria

Arjun Lakshman, S. Vincent Rajkumar, Francis K. Buadi et al. · Blood Cancer Journal · 2018 · 289 citations · Full text

Medicine, Hematology, Oncology +12

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

Eli Muchtar, Angela Dispenzieri, Nelson Leung et al. · Leukemia · 2018 · 128 citations

Medicine, Pathology, Molecular Pathology +7

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response

Nadine Abdallah, S. Vincent Rajkumar, Patricia T. Greipp et al. · Blood Cancer Journal · 2020 · 118 citations · Full text

Medicine, Hematology, Oncology +12